Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» chronic kidney disease
chronic kidney disease
Medicare is using one of its biggest hammers to try to fix the dialysis system: how providers are paid
Stat
Mon, 09/19/22 - 09:06 am
dialysis
chronic kidney disease
Medicare
payers
Aria Pharmaceuticals Secures Six Provisional Patents for Pipeline Candidates
BioSpace
Wed, 08/31/22 - 10:25 am
Aria Pharmaceuticals
patents
lupus
idiopathic pulmonary fibrosis
IPH
chronic kidney disease
Positive data on Kerendia in chronic kidney disease and type 2 diabetes
Pharma Letter
Mon, 08/29/22 - 10:38 am
Bayer
Kerendia
chronic kidney disease
ESCC
Novartis' MS drug Gilenya could inspire new chronic kidney disease treatment
Fierce Biotech
Fri, 08/19/22 - 10:47 am
Novartis
Gilenya
kidney disease
chronic kidney disease
ADA: Bayer builds its case for potential kidney disease blockbuster Kerendia
Fierce Pharma
Tue, 06/7/22 - 10:13 am
ADA
diabetes
Bayer
chronic kidney disease
Kerendia
AstraZeneca, FibroGen can't agree on roxadustat's path forward in chronic kidney disease after FDA rejection
Fierce Pharma
Tue, 05/10/22 - 10:40 am
AstraZeneca
FibroGen
chronic kidney disease
roxadustat
GSK goes for gold as FDA starts review of daprodustat
Pharmaforum
Tue, 04/19/22 - 10:47 am
GSK
chronic kidney disease
anemia
daprodustat
FDA
FDA rejects Akebia drug, dealing another blow to anemia pills
BioPharma Dive
Thu, 03/31/22 - 10:24 am
Akebia Therapeutics
vadadustat
FDA
chronic kidney disease
anemia
Lilly, BI-Partnered Kidney Trial Stopped Early Due to Positive Results
BioSpace
Wed, 03/16/22 - 11:20 pm
Eli Lilly
Boehringer Ingelheim
clinical trials
chronic kidney disease
empagliflozin
FDA denies Ardelyx’s appeal against kidney drug rejection, hammering another nail in tenapanor’s coffin
Fierce Biotech
Thu, 02/10/22 - 10:30 am
Ardelyx
FDA
complete response letter
tenapanor
chronic kidney disease
GSK pulls off clean sweep of endpoint hits in anemia phase 3, positioning it to leapfrog AstraZeneca
Fierce Biotech
Mon, 11/8/21 - 10:47 am
GSK
chronic kidney disease
cliincal trials
FDA
AstraZeneca
anemia
erythropoietin
FibroGen
Ardelyx Prepares for Battle with FDA Over Rejected CKD Drug
BioSpace
Sun, 11/7/21 - 10:47 pm
Ardelyx
chronic kidney disease
tenapanor
FDA
Ardelyx axes 65% of workforce with no clarity from FDA on kidney drug's future
Fierce Pharma
Wed, 10/13/21 - 10:53 pm
Ardelyx
layoffs
chronic kidney disease
CinCor Raises $143 Million To Fund Innovation in Hypertension Research
BioSpace
Wed, 10/13/21 - 10:36 pm
CinCor Pharma
funding
hypertension
chronic kidney disease
Cara’s Korsuva is first drug cleared for itching in dialysis patients
Pharmaforum
Tue, 08/24/21 - 10:52 pm
Cara Therapeutics
Korsuva
dialysis
chronic kidney disease
After FDA snub, EMA backs FibroGen, Astellas’ roxadustat
Pharmaforum
Fri, 08/20/21 - 10:51 am
Europe
FibroGen
Astellas
Evrenzo
anemia
chronic kidney disease
FDA declines to approve FibroGen's anemia drug
Yahoo/Reuters
Wed, 08/11/21 - 12:07 pm
FibroGen
FDA
anemia
chronic kidney disease
roxadustat
Ardelyx chops a third of its staff after stock-crushing failure in chronic kidney disease
Endpoints
Wed, 08/4/21 - 11:00 am
Ardelyx
chronic kidney disease
layoffs
tenapanor
FDA turns down Ardelyx’s chronic kidney disease drug and asks for another trial
MedCity News
Thu, 07/29/21 - 11:06 pm
Ardelyx
tenapanor
FDA
chronic kidney disease
FibroGen slides after FDA posted documents ahead of AdCom meeting on Roxadustat
Seeking Alpha
Tue, 07/13/21 - 11:06 am
FibroGen
FDA
roxadustat
advisory panels
chronic kidney disease
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »